Key Insights

Highlights

Treatment Research

1 treatments under study, led by Serum Pai1 Alpha Analysis

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT04997928Unknown

PAI-1 Levels and Predicting Covid-19 Patients' Prognosis

Showing all 1 trials

Research Network

Common Treatments

  • Serum Pai1 Alpha Analysis1

Active Sponsors

  • Saglik Bilimleri Universitesi1

Related Conditions

  • Healthy Control Patients Of The Same Age1
  • Symptomatic Covid 19 Positive Patients Who Require Hospitalization1
  • Patients Who Did Not Vaccinate Against Covid191
  • Covid19 Positivity Confirmed With Pcr Positivity In The Nasopharyngeal Swab1

Activity Timeline